Portfolio Update – CSL Limited
CSL: This morning, a world's leader in manufacturing medicines from human blood, gave a trading update that came in below market expectations as continued strength in the USD impacted the translation of foreign earnings. The HNW Equity Portfolio holds an 8.5% [...]